Trial Details
COMPLETEDBasic Information
| Clinical ID | c2317 |
|---|---|
| Identifier | NCT03681067 |
| Trial Title | A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: GSK1070806|DRUG: Placebo- sodium chloride |
Participant Information
| Sponsor | University of Birmingham |
|---|---|
| City | Birmingham |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2019-02-20 |
|---|---|
| Primary Completion Date | 2020-06-02 |
| Completion Date | 2020-06-02 |